Literature DB >> 22484304

Cognitive impairment and dementia in Parkinson's disease.

Javier Pagonabarraga1, Jaime Kulisevsky.   

Abstract

Relatively subtle cognitive disturbances may be present from the initial stages of Parkinson's disease (PD) that progress in many patients to a more severe cognitive impairment and dementia. Several of the initial deficits are ascribed to failure in the frontal-striatal basal ganglia circuits and involve executive defects in planning, initiation, monitoring of goal-directed behaviors and working-memory. Other non-demented PD patients also exhibit visuospatial and memory deficits more representative of posterior cortical functioning and fail performing naming or copying tasks. Major differences in the overall rate of cognitive decline among PD patients support the co-existence of at least two patterns of involution, differentiating a relatively slow decline of fronto-striatal deficits from a more rapid decline of posterior-cortical deficits, with different pathophysiological substrates, genetics, prognosis and response to drugs used to treat the motor symptoms of PD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22484304     DOI: 10.1016/j.nbd.2012.03.029

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  63 in total

1.  Is cognitive stability in Parkinson's disease a predictable phenomenon? A 5-year follow-up study.

Authors:  Maria Elena Di Battista; Alfonso Rubino; Marcella Valente; Patrizia Giustini; Nicola Vanacore; Giuseppe Meco
Journal:  J Neural Transm (Vienna)       Date:  2015-08-28       Impact factor: 3.575

Review 2.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

3.  The Box Task: A tool to design experiments for assessing visuospatial working memory.

Authors:  Roy P C Kessels; Albert Postma
Journal:  Behav Res Methods       Date:  2018-10

4.  Adverse effects produced by different drugs used in the treatment of Parkinson's disease: A mixed treatment comparison.

Authors:  Bao-Dong Li; Zhen-Yun Bi; Jing-Feng Liu; Wei-Jun Si; Qian-Qian Shi; Li-Peng Xue; Jing Bai
Journal:  CNS Neurosci Ther       Date:  2017-09-04       Impact factor: 5.243

5.  Default-mode network connectivity in cognitively unimpaired drug-naïve patients with rigidity-dominant Parkinson's disease.

Authors:  Yanbing Hou; Chunyan Luo; Jing Yang; Ruwei Ou; Wanglin Liu; Wei Song; Qiyong Gong; Huifang Shang
Journal:  J Neurol       Date:  2016-11-15       Impact factor: 4.849

6.  Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders.

Authors:  Stéphane Potvin; Ginette Aubin; Emmanuel Stip
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-06-13       Impact factor: 5.270

7.  Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Brenna A Cholerton; Cyrus P Zabetian; Jia Y Wan; Thomas J Montine; Joseph F Quinn; Ignacio F Mata; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; James B Leverenz; Karen L Edwards
Journal:  Mov Disord       Date:  2014-04-07       Impact factor: 10.338

8.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

9.  Initial cognitive decline is associated with cortical thinning in early Parkinson disease.

Authors:  Joana B Pereira; Per Svenningsson; Daniel Weintraub; Kolbjørn Brønnick; Alexander Lebedev; Eric Westman; Dag Aarsland
Journal:  Neurology       Date:  2014-05-07       Impact factor: 9.910

Review 10.  [Therapy for patients with dementia. Treatment strategies in the elderly].

Authors:  F Jessen
Journal:  Internist (Berl)       Date:  2014-07       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.